Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Obstet Gynaecol Res ; 42(11): 1489-1494, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27436681

RESUMO

AIM: To compare the efficacy of two mechanical devices for pre-induction of labor cervical ripening: the Foley catheter and the Cook cervical ripening balloon. METHODS: This interventional study included 78 postdate primigravid women randomly allocated into two groups: the Foley or Cook balloon catheter. Removal of the catheters was planned approximately 12 h after insertion if spontaneous expulsion had not occurred. The main outcome measures included changes in Bishop score, insertion to delivery time, mode of delivery and occurrence of adverse effects. RESULTS: Spontaneous expulsion of the Foley catheter was encountered more frequently than the Cook (89.2% vs 78.4%; P = 0.03). However, the median Bishop score was significantly higher when using the Cook compared with the Foley catheter after balloon removal (6 vs 5; P = 0.03). The duration from balloon insertion to expulsion and from insertion to delivery was significantly shorter in the Foley group compared with the Cook balloon group (6:19 ± 2:1 vs 7:26 ± 2:25 h; P = 0.03 and 13:50 ± 4:00 vs 15:16 ± 4:30 h; P = 0.03, respectively). There were no significant differences in other outcomes, such as the amount of oxytocin units used, mode of delivery, pain encountered during or after insertion and overall patient satisfaction. CONCLUSIONS: Use of the Cook cervical ripening catheter results in greater cervical ripening compared with the Foley catheter. However, the duration from balloon insertion to expulsion and then delivery were significantly shorter when using the Foley catheter; therefore, we recommend its use, particularly in low resource settings.


Assuntos
Cateterismo/métodos , Maturidade Cervical , Trabalho de Parto Induzido/métodos , Cateterismo Urinário/métodos , Adulto , Cateterismo/efeitos adversos , Colo do Útero , Feminino , Idade Gestacional , Número de Gestações , Humanos , Trabalho de Parto Induzido/efeitos adversos , Dor/complicações , Satisfação do Paciente , Gravidez , Complicações na Gravidez/epidemiologia , Estudos Prospectivos , Cateterismo Urinário/efeitos adversos , Adulto Jovem
2.
Eur J Contracept Reprod Health Care ; 18(4): 300-8, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23751152

RESUMO

OBJECTIVE: To investigate whether sublingual misoprostol administered one hour before intrauterine device (IUD) insertion reduces failed insertions, insertion-related complications and pain in parous women delivered only by elective caesarean section (CS). METHODS: Single-blind randomised controlled trial conducted in Ismailia, Egypt, between July 2010 and December 2011. Women who had never delivered otherwise than by elective CS and desirous of using an IUD were randomly allocated to receive sublingually 400 µg misoprostol and 100 mg diclofenac (misoprostol group) or 100 mg diclofenac alone (control group) one hour before IUD insertion. Outcome measures were failed insertion, ease of insertion judged by the investigators, insertion-related complications, and patients' satisfaction. RESULTS: In all, 255 women (130 and 125 in the study and control groups, respectively) had an IUD inserted. Seven insertions failed: five in the control group, and two in the study group. Ease of insertion and patients' satisfaction were comparable in both groups. Abdominal pain and nausea were the commonest side effects reported in the misoprostol group. CONCLUSION: Sublingual administration of misoprostol one hour before IUD insertion in parous women with no previous vaginal delivery does not facilitate the procedure and may cause undesirable side effects. This approach is not recommended as a standard treatment.


Assuntos
Dispositivos Intrauterinos de Cobre , Misoprostol/uso terapêutico , Ocitócicos/uso terapêutico , Dor/prevenção & controle , Implantação de Prótese/métodos , Administração Sublingual , Adolescente , Adulto , Anti-Inflamatórios não Esteroides/uso terapêutico , Diclofenaco/uso terapêutico , Quimioterapia Combinada , Egito , Feminino , Humanos , Implantação de Prótese/efeitos adversos , Método Simples-Cego , Adulto Jovem
3.
Arch Gynecol Obstet ; 287(6): 1173-80, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23274790

RESUMO

PURPOSE: To assess sexual function among married women and determine associated risk factors for sexual dysfunction. PARTICIPANTS AND METHOD: Cross-sectional hospital-based study involving 509 non-pregnant married females 20-59 years old who were enrolled into the study after approval of the ethics committee. The study population was recruited among women attending gynecology outpatient clinic or their relatives visiting inpatients of obstetrics and gynecology department at Suez Canal University Hospital. Female and male partner-related data were collected using an interview questionnaire. Sexual dysfunction was assessed using female sexual function index (FSFI). RESULTS: Mean female age was 39.5 years. About half of the participants were premenopausal (48.7 %). Most of the females were circumcised (71.7 %). Desire and Orgasm domains were the most affected with 52.8 % of the participants having sexual dysfunction. Total FSFI score of ≤26.55 was the cutoff value for diagnosis of FSD and female age, postmenopausal status, duration of marriage, circumcision, partner's age, and the presence of male sexual dysfunction were found to be significant associated factors with FSD. CONCLUSION: FSD is highly prevalent in Egypt and orgasm and desire scores were the most affected domains. Several personal (female age, postmenopausal status, duration of marriage and circumcision) and male partner (age, and the presence of sexual dysfunction) factors were significantly associated.


Assuntos
Disfunções Sexuais Fisiológicas/epidemiologia , Disfunções Sexuais Psicogênicas/epidemiologia , Adulto , Circuncisão Feminina/efeitos adversos , Estudos Transversais , Egito/epidemiologia , Disfunção Erétil , Terapia de Reposição de Estrogênios , Feminino , Humanos , Masculino , Estado Civil , Casamento , Pessoa de Meia-Idade , Orgasmo , Pós-Menopausa , Ejaculação Precoce , Fatores de Risco , Inquéritos e Questionários
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA